financetom
Business
financetom
/
Business
/
Embraer Q4 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Embraer Q4 Adjusted Earnings, Revenue Rise
Mar 11, 2026 6:50 AM

05:38 AM EST, 03/06/2026 (MT Newswires) -- Embraer ( EMBJ ) reported Q4 adjusted earnings Friday of $0.45 per diluted share, up from $0.25 a year earlier.

Analysts polled by FactSet expected $0.78.

Revenue for the quarter ended Dec. 31 was $2.65 billion, up from $2.31 billion a year earlier.

Analysts polled by FactSet expected $2.54 billion.

For full-year 2026, Embraer ( EMBJ ) guided to consolidated revenues of $8.2-$8.5 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With The Rise In Nvidia Stock Today?
What's Going On With The Rise In Nvidia Stock Today?
Oct 24, 2025
Nvidia Corporation ( NVDA ) shares are trading higher Friday. Schneider Electric (OTC:SBGSY) announced it is collaborating with Nvidia ( NVDA ) to develop an 800 VDC sidecar capable of powering racks of up to 1.2 MW to support next-generation Nvidia GPUs and future iterations of Nvidia ( NVDA ) accelerated computing infrastructure. What To Know: Schneider Electric strengthened its...
Mundoro Capital Up on Strategic Private Placement With Lead Orders From Existing Shareholders
Mundoro Capital Up on Strategic Private Placement With Lead Orders From Existing Shareholders
Oct 24, 2025
01:45 PM EDT, 10/24/2025 (MT Newswires) -- Mundoro Capital ( MUNMF ) shares were last seen up 8% on Friday after it said it will raise up to $1.5 million in a non-brokered private placement. The company said it will place up to 5.8-million shares priced at at $0.26 in the financing. Strategic lead orders from existing shareholders demonstrate strong...
Syndax's Revumenib Gets FDA Approval for Acute Myeloid Leukemia
Syndax's Revumenib Gets FDA Approval for Acute Myeloid Leukemia
Oct 24, 2025
01:51 PM EDT, 10/24/2025 (MT Newswires) -- Syndax's (SNDX) revumenib was approved by the US Food and Drug Administration as a treatment for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation, the regulator said Friday. The drug was approved for use in adults and children at least one year old who have no satisfactory alternative treatment options,...
Westinghouse Air Brake Technologies Insider Sold Shares Worth $577,108, According to a Recent SEC Filing
Westinghouse Air Brake Technologies Insider Sold Shares Worth $577,108, According to a Recent SEC Filing
Oct 24, 2025
02:27 PM EDT, 10/24/2025 (MT Newswires) -- Gregory Sbrocco, Executive Vice President, Operations, on October 23, 2025, sold 2,953 shares in Westinghouse Air Brake Technologies ( WAB ) for $577,108. Following the Form 4 filing with the SEC, Sbrocco has control over a total of 17,829 common shares of the company, with 17,829 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943452/000162828025046235/xslF345X05/wk-form4_1761330250.xml Price:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved